The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells

The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells Synthesis and toxicity towards normal and cancer cell lines of benzimidazolequinones containing fused aromatic rings and 2-aromatic ring substituents New 2-substituted indoloquinone mitomycin analogs Design, synthesis and antitumour activity of novel 5(6)-amino-benzimidazolequinones containing a fused morpholine Modification of cellular DNA by synthetic aziridinomitosenes Heterocyclic quinones. XVII. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8-quinazolinedione Preparation and antitumor activity of 7-substituted 1,2-aziridinomitosenes 2-Cyclopropylindoloquinones and Their Analogues as Bioreductively Activated Antitumor Agents:  Structure−Activity in Vitro and Efficacy in Vivo Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of minimal DNA-intercalating agents which may not act via topoisomerase II 2-Nitroimidazole dual-function bioreductive drugs: studies on the effects of regioisomerism and side-chain structural modifications on differential cytotoxicity and radiosensitization by aziridinyl and oxiranyl derivatives